TG Therapeutics Inc (NASDAQ: TGTX): Reassessing Prospects
The Vanguard Group, Inc. has recently announced that it has increased stake in TG Therapeutics Inc (NASDAQ:TGTX) by 0.07%. After grabbing 13.06 million shares, the institutional investor is now in possession of 9159.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.63% having worth around $167.36 million. Moreover, […]
